Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications
World Journal of Clinical Oncology · 02.11.2026
DOI: 10.5306/wjco.126700 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Clinical Oncology, online erschienen am 02.11.2026. Verfasst von Ludovico Carbone und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Carbone, L., Marrelli, D., Barbato, B., Visani, A., Corso, G., & Roviello, F. (2026). Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications. World Journal of Clinical Oncology. https://doi.org/10.5306/wjco.126700
Vancouver
Carbone L, Marrelli D, Barbato B, Visani A, Corso G, Roviello F. Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications. World Journal of Clinical Oncology. 2026. doi:10.5306/wjco.126700
BibTeX
@article{Carbone2026,
author = {Carbone, Ludovico and Marrelli, Daniele and Barbato, Bina and Visani, Aurora and Corso, Giovanni and Roviello, Franco},
title = {Specific molecular signature redefines the role of posterior and para-aortic (D2 plus) lymphadenectomy in gastric cancer: Rethinking surgical indications},
journal = {World Journal of Clinical Oncology},
year = {2026},
doi = {10.5306/wjco.126700}
}
EUVIMED